CLINICAL_TRIALS
trial_result
· 2021-12-07
Clinical Trial Update: A Dose-range Finding Study of MAA868 in Patients With Atrial Fibrillation [Phase 2]
Summary
Phase 2 dose-range finding study of MAA868 in atrial fibrillation completed; results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Anthos Therapeutics, Inc. | Conditions: Atrial Fibrillation | Phase 2 | Status: COMPLETED | Results posted: 2021-12-07